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Abstract 
Ligand-based virtual screening of large small-molecule databases is an important step in the early stages of drug 
development. It is based on the similarity principle and is used to reduce the chemical space of large databases to a 
manageable size where chosen ligands can be experimentally tested. Ligand-based virtual screening can also be used 
to identify bioactive molecules with different basic scaffolds compared to already known bioactive molecules, thus 
having the potential to increase the structural variability of compounds. Here, we present an interface between the 
popular molecular graphics system PyMOL and the ligand-based virtual screening software LiSiCA available at http://
insilab.org/lisica-plugin and demonstrate how this interface can be used in the early stages of drug discovery process.
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Background
Virtual screening (VS) of large compound libraries has 
become a standard computational technique in modern 
drug discovery pipeline [1]. VS is used to search com-
pound libraries to identify structures which are puta-
tive binders for a particular drug target. The approach 
helps in reducing the enormous chemical space of large 
databases to a manageable size that can be subjected to 
experimental testing.
Ligand-based virtual screening (LBVS) is one of the 
two broad approaches of VS, the other being structure-
based virtual screening. The central assumption of LBVS 
is that similar structures have similar biochemical activi-
ties [2]. LBVS requires at least one known active ligand 
that binds to the drug target. The goal of LBVS is to 
identify molecules with different basic scaffolds but with 
similar or better biochemical activity compared to the 
already known bioactive ligands—a concept referred to 
as scaffold hopping [3].
Efficient visual examination and comparison of pre-
dicted ligands is an important part of VS studies, 
contributing crucially to the choice of compounds that 
will be subsequently biochemically or biologically evalu-
ated. PyMOL [4] is a widely used molecular graphics 
program, which has evolved into a platform for several 
plugins that use its versatile visualization capabilities.
In the field of molecular interactions, several exten-
sively used plugins for PyMOL were developed. The 
Autodock Vina plugin [5] covers all functionalities of an 
entire molecular docking workflow, including prepara-
tion, execution and analysis of docking input/output files. 
The APBS plugin [6] is an interface to the adaptive Pois-
son-Boltzmann solver (APBS) program [7] and enables 
electrostatics calculations and the visualization of poten-
tial energy surfaces and charge densities on protein sur-
faces. CASTp [8–10] detects pockets and voids in protein 
structures to determine and characterize binding sites, 
while Caver [11, 12] performs calculations of substrate 
pathways and entrance tunnels in protein structures, and 
enables their visualization.
In this work, we describe a plugin for PyMOL which 
allows carrying out 2D or 3D ligand-based virtual screen-
ings of large small-molecule databases with immediate 
subsequent visualization of predicted ligands. The devel-
oped plugin represents an interface between PyMOL and 
LiSiCA, an LBVS software based on a graph theoretical 
maximum clique algorithm (http://insilab.org/maxclique) 
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[13, 14]. The main purpose of this interface is to enable 
visualization of large amounts of data returned from 
LiSiCA’s output within the preferred environment of 
many researchers. Thus, LBVS becomes straightforward 
for scientists who may not be comfortable with using 
the command line interface. The plugin allows specify-
ing the reference ligand and the target database, defining 
all of the LiSiCA’s options, loading previously completed 
projects and outputting a list of the highest scoring mole-
cules that can be visualized in the PyMOL viewer. LiSiCA 




The general requirement for the LiSiCA plugin is an 
installed PyMOL program (version >1.4) with plugin 
support. LiSiCA software executable used by the plugin 
runs under Linux and Windows operating systems. The 
plugin uses the native Python library Tkinter (https://
wiki.python.org/moin/TkInter) and is thus dependent on 
the underlying Tcl/Tk libraries (version ≥8.5). These, if 
not installed by default, are available in the package man-
agement systems of most Linux distributions; they are 
installed together with PyMOL in Windows.
Installation
Standardized PyMOL plugin installation has been 
adopted for LiSiCA plugin. The user installs the LiSiCA 
plugin through the PyMOL’s Plugin Manager interface by 
providing lisica.py file downloaded from http://insilab.
org/lisica-plugin. When first started, the lisica.py script 
automatically downloads all the remaining required files 
(executable files, log files, icon files and the python mod-
ules) from the remote server to the .lisicagui directory 
located in the user’s home directory, which requires a sta-
ble internet connection.
Plugin graphical user interface
The graphical user interface (GUI) for LiSiCA plugin 
consists of four distinct tabs: ‘Inputs’, ‘Load Project’, ‘Out-
puts’ and ‘About’ tab (Fig. 1).
Inputs tab
The ‘Inputs’ tab provides an interface, in which all all the 
input parameters and options for the virtual screening 
using the LiSiCA software can be defined. The reference 
and the target mol2 files are specified in the respective 
entry widgets and the input validation then checks if the 
entered mol2 files exist and if they are in the required 
mol2 format before the execution of the LiSiCA software. 
Two-dimensional (2D) or three-dimensional (3D) virtual 
screening can be chosen using the appropriate radio but-
ton labeled product graph dimensions. The GUI then pre-
sents further set of input options according to this choice: 
for the 2D screening, the maximum allowed shortest path 
difference defined as the maximum difference between 
the numbers of covalent bonds between two matched 
atom pairs; for the 3D screening the maximum allowed 
spatial distance difference defined as the tolerance in 
Ångströms between the coordinates of two matched 
atom pairs. For both, 2D and 3D screening the user can 
choose the number of highest ranking molecules to be out-
putted. For 3D screening, the number of conformations 
of a target molecule to be shown in the final output can 
also be specified. User can also specify if hydrogen atoms 
in the input ligands should be considered in the genera-
tion of the molecular and subsequent product graph. By 
default, hydrogen atoms are not considered to achieve 
faster screening.
LiSiCA runs in parallel on multiple CPU cores, thus 
the plugin allows the user to choose the number of CPU 
cores to be used. The maximum number of CPU cores 
available in the system is detected automatically, and by 
default, all available cores are used.
The location where the results of LiSiCA are to be 
saved is also specified in the ‘Inputs’ tab. The results files 
of each LiSiCA run include the text file containing on 
each line a target molecule’s ID and Tanimoto coefficient 
expressing its similarity to the reference molecule. Addi-
tionally, mol2 files are created, which contain aligned 
coordinates of the reference and the target molecules’ 
atoms. Each mol2 file also contains a comment section 
expressing the common atoms found in both molecules.
An additional feature in the ‘Inputs’ tab is the display 
of the command that can be entered in the command 
Fig. 1 LiSiCA ‘Inputs’ tab, where all the LiSiCA’s options are displayed. 
In the bottom window the command is displayed that can be used in 
the command-line to run the standalone executable
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line for the underlying LiSiCA executable. Potentially, 
users would prefer to use LiSiCA plugin to reliably cre-
ate the appropriate screening command and then use the 
obtained command to run the standalone executable on a 
large computer cluster.
Once the user sets all the parameters in the ‘Inputs’ tab, 
the screening can be started by clicking the ‘GO’ button. 
This initiates the validation of values in all input widgets, 
followed by the execution of the LiSiCA software in the 
background. If any inputs are invalid, a dialog box appears 
with the error or alert message. In case of successful vali-
dation, the progress bar indicates that the LiSiCA execut-
able is running. When the process finishes and the output 
files are written to disk the progress bar is terminated and 
the ‘Outputs’ tab with the results is automatically opened.
Load Project tab
The ‘Load Project’ tab allows the user to recover the 
results and visualization of a previous LiSiCA’s screening 
run, by selecting the directory containing the output text 
file and mol2 files. The ‘Load’ button loads all the results 
in the ‘Outputs’ tab.
Outputs tab
The ‘Outputs’ tab presents the LiSiCA’s results in a logi-
cal and interactive manner (Figs.  2, 3). The results are 
presented as two multicolumn lists. On the left hand side 
of the tab, a multicolumn list is displayed with ranked—
according to the decreasing Tanimoto coefficients—tar-
get molecules. Each row contains the rank and the name 
of a target molecule, and its Tanimoto coefficient express-
ing the similarity between it and the reference com-
pound. By selecting a particular row, the corresponding 
target molecule is displayed in the PyMOL viewer along 
with the reference ligand. If 2D screening was performed, 
the two molecules are displayed side-by-side for easy vis-
ual comparison (Fig. 2); in case of the 3D screening, the 
two molecules are superimposed upon each other using 
the PyMOL pair fitting function, thus making it possible 
to visually compare the spatial arrangement of potentially 
important functional groups (Fig. 3). Moreover, by click-
ing on a target molecule, the root-mean-square devia-
tion is calculated between the reference and the target 
matched atoms.
The right hand site list shows the corresponding atom 
pairs between the currently selected target molecule and 
the reference molecule. This list contains atom numbers 
as well as atom types of the matched reference and tar-
get molecule atoms that were recognized as similar by 
LiSiCA. By clicking on a row, the corresponding atom 
pair is selected and highlighted in the PyMOL viewer, 
making it easy to identify the common substructures in 
both compounds.
About tab
The ‘About’ tab contains the ‘Product Version Informa-
tion’ section where the LiSiCA GUI version currently 
used is specified. In the same section, the user can get 
information on any new updates if available.
Results and discussion
Here, the LiSiCA plugin was used to screen a known 
inhibitor of the Mycobacterium tuberculosis InhA 
enzyme [15], an enoyl-acyl carrier protein reductase, 
against the ZINC Drugs Now database [16] contain-
ing approximately 10 million compounds (Fig.  2). InhA 
is a key enzyme involved in the fatty acid biosynthesis 
pathway II in the M. tuberculosis bacteria. Compared to 
isoniazid, the first-line drug for the treatment of tubercu-
losis, which also targets InhA, this active compound does 
not need preliminary enzymatic transformation with 
mycobacterial catalase-peroxidase enzyme (KatG) to 
become active. As KatG mutations are the most common 
mechanism for isoniazid resistance, this compound and 
its derivatives are potentially promising candidates for 
the treatment of infections caused by isoniazid resistant 
strains. We used the 2D screening option for LiSiCA with 
all the other options set to default. After screening, which 
took about an hour to complete on 8 CPU cores, the tar-
get compounds were ranked according to their topologi-
cal similarity to the reference compound expressed by 
the Tanimoto coefficients. The one hundred highest scor-
ing molecules were visually inspected using the LiSiCA 
plugin in the PyMOL viewer and the most interesting 
molecules, that is, ones having different overall scaffolds 
from the reference ligand, could be purchased from ven-
dors and biochemically tested for their IC50 values. For 
example, compound ZINC00684054 (Fig.  2) has a very 
different scaffold compared to the reference molecule, 
and might, if found active, be a good starting point in 
a hit to lead procedure; especially as the aromatic rings 
allow much room for substitution and therefore potential 
optimization.
Previous experimental validation of LiSiCA 
on butyrylcholinesterase enzyme
The LiSiCA software was previously tested for its abil-
ity to discriminate active from inactive molecules in the 
Directory of Useful Decoys Enhanced Database [17] (see 
Ref. 14). In that study we showed that both the 2D and 
3D screening options outperform a competing ShaEP 
method [18]. With LiSiCA we obtained an average area 
under the ROC curve of 0.71 ± 0.15 and 0.67 ± 0.16, for 
2D and 3D screening respectively, whereas with ShaEP 
we obtained an average of 0.57 ±  0.11, which is signifi-
cantly lower compared to the results of both the LiSiCA’s 
screening options. We also employed LiSiCA for the 
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discovery of new nanomolar butyrylcholinesterase inhib-
itors [14]; we used the bioactive conformation of a known 
inhibitor (PDB code: 3F9) [19] obtained from the butyryl-
cholinesterase enzyme (PDB ID: 4TPK) as a reference 
molecule and screened it against the ZINC Drugs Now 
database using the LiSiCA’s 3D option. To cover as much 
conformational space as possible, we initially prepared 
on average 188 conformers per each database compound. 
Finally, the 30 best-ranked ZINC compounds with the 
highest scoring Tanimoto coefficient were purchased 
and tested biochemically for their IC50 values: 53  % of 
the purchased compounds showed >50  % inhibition at 
10 μM concentration, while 17 % exhibited inhibition in 
the nanomolar range (IC50 values ranging from 80 to 
Fig. 2 Example of the plugin’s output after 2D screening. On the left hand side two lists are shown. The list on the left shows the highest scoring 
target molecules ranked by the Tanimoto coefficient. The currently selected target molecule is displayed in the PyMOL visualizer on the right side of 
the screen (cyan carbon atoms), along with the reference molecule (green carbon atoms). The second list on the left hand side of the screen displays 
atom pairs (ID number based on the mol2 file and SYBYL atom types) that form the common substructure of the reference and target molecule. 
The selection of an atom pair can be immediately visualized in the PyMOL visualizer by purple selection squares (not shown). The Tanimoto coef-
ficient and the molecule names are displayed for clarity and are not shown in the PyMOL viewer
Fig. 3 Example of the plugin’s output after 3D screening, where two molecules are superimposed based on the atom pairs displayed on the left 
hand side list. Here, two comparable bromine atoms are selected. Color codes are the same as in Fig. 2. The Tanimoto coefficient and the molecule 
names were added for clarity and are not shown in the PyMOL viewer
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840 nM). While none of the nanomolar inhibitors had an 
IC50 as low as the reference compound (21  nM), all of 
them exhibited a significantly different molecular struc-
ture, and also had higher binding-efficiency indexes com-
pared to the reference molecule. LiSiCA thus proved its 
ability for obtaining compounds with diverse scaffolds, 
while the low binding-efficiency index of the structures 
enables their further optimization.
Conclusion
We present a novel plugin for the widely used molecu-
lar graphics system PyMOL, which allows perform-
ing ligand-based virtual screening studies using LiSiCA 
software. The plugin enables simple preparation of the 
LiSiCA’s screening procedure, with the ability to custom-
ize all the available options for LiSiCA. As visual support 
is an important aspect in virtual screening, the plugin is 
expected to enhance the ligand-based virtual screening 
efforts. In the future, we will extend the plugin with a 
knowledge-based bioisostere similarity search tool, hope-
fully furthering the plugin’s usefulness in finding novel 
active compounds with highly diverse structures.
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